Related Experiment Video
Updated: Jun 9, 2026

Molecular Modulation by Lentivirus-Delivered Specific shRNAs in Endoplasmic Reticulum Stressed Neurons
Published on: April 24, 2021
CK2 inhibition induces apoptosis via the ER stress response
Andrea Hessenauer1, Carolin C Schneider, Claudia Götz
1Allgemeine Zoologie und Endokrinologie, Universität Ulm, Ulm, Germany. andrea.hessenauer@uni-ulm.de
Abstract:
Protein kinase CK2 is a ubiquitously expressed serine/threonine kinase consisting of two catalytic α/α' and two regulatory β subunits. Expression of CK2 is highly elevated in tumor cells where it protects cells from apoptosis. Accordingly inhibition of CK2 is known to induce programmed cell death, making it a promising target for cancer therapy. In the present study we investigated apoptosis induction by the CK2 inhibitor 4,5,6,7-tetrabromobenzotriazole (TBB) in prostate tumor cells. In contrast to PC-3 cells LNCaP cells respond to CK2 inhibition with apoptosis. Most interestingly we found the mitochondrial pathway induced in LNCaP as well as in PC-3 cells as monitored by down-regulation of bcl-2 and subsequent cytochrome c release. In both cell lines activation of caspase 9 was not detected. Instead, an activation of the endoplasmic reticulum (ER) stress response in LNCaP cells after treatment with the CK2 inhibitor TBB was found. We show that this ER stress response led to an up-regulation of the death receptor DR5 and subsequent apoptosis in LNCaP cells.
Insights
Protein kinase CK2 inhibition induces apoptosis in prostate cancer cells. The CK2 inhibitor TBB activates endoplasmic reticulum stress, upregulating DR5 and leading to programmed cell death in LNCaP cells.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Protein kinase CK2 (CK2) is highly expressed in tumor cells, promoting survival by inhibiting apoptosis.
- CK2 is a validated cancer target, as its inhibition can induce programmed cell death.
- The CK2 inhibitor 4,5,6,7-tetrabromobenzotriazole (TBB) has shown potential in cancer therapy.
Purpose of the Study:
- To investigate the induction of apoptosis by the CK2 inhibitor TBB in prostate tumor cells.
- To elucidate the molecular mechanisms underlying TBB-induced apoptosis in different prostate cancer cell lines (LNCaP and PC-3).
Main Methods:
- Treatment of LNCaP and PC-3 prostate cancer cells with the CK2 inhibitor TBB.
- Analysis of apoptosis induction, mitochondrial pathway activation (bcl-2 downregulation, cytochrome c release), and endoplasmic reticulum (ER) stress response.
- Assessment of caspase 9 activation and death receptor (DR5) expression.
Main Results:
- LNCaP cells, but not PC-3 cells, responded to CK2 inhibition with apoptosis.
- Both cell lines exhibited mitochondrial pathway activation, evidenced by bcl-2 downregulation and cytochrome c release.
- Caspase 9 activation was not detected; however, TBB induced an ER stress response in LNCaP cells, leading to DR5 upregulation and subsequent apoptosis.
Conclusions:
- CK2 inhibition by TBB induces apoptosis in prostate cancer cells through both mitochondrial and ER stress-dependent pathways.
- The ER stress response and subsequent DR5 upregulation play a critical role in TBB-induced apoptosis in LNCaP cells.
- CK2 represents a significant therapeutic target for prostate cancer, with TBB demonstrating potential for inducing tumor cell death.
Related Concept Videos
The Intrinsic Apoptotic Pathway
The Extrinsic Apoptotic Pathway
Caspases
Cellular Injury V: Apoptosis and Autophagy
Regulation of the Unfolded Protein Response
Inhibition of Cdk Activity
